Evidence map›Paper›PMID 30362368›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2019

Refining the structure-activity relationships of 2-phenylcyclopropane carboxylic acids as inhibitors of O-acetylserine sulfhydrylase isoforms.

Joana Magalhães, Nina Franko, Giannamaria Annunziato, Marco Pieroni, Roberto Benoni, Anna Nikitjuka, Andrea Mozzarelli, Stefano Bettati, Anna Karawajczyk, Aigars Jirgensons and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Joana Magalhãesa P4T group, Department of Food and Drug, University of Parma, Parma, Italy.
Nina Frankob Laboratory of Biochemistry and Molecular Biology, Department of Food and Drug , University of Parma , Parma , Italy.
Giannamaria Annunziatoa P4T group, Department of Food and Drug, University of Parma, Parma, Italy.
Marco Pieronia P4T group, Department of Food and Drug, University of Parma, Parma, Italy.
Roberto Benonib Laboratory of Biochemistry and Molecular Biology, Department of Food and Drug , University of Parma , Parma , Italy.
Anna Nikitjukac Latvian Institute of Organic Synthesis , Riga , Latvia.
Andrea Mozzarellib Laboratory of Biochemistry and Molecular Biology, Department of Food and Drug , University of Parma , Parma , Italy.
Stefano Bettatib Laboratory of Biochemistry and Molecular Biology, Department of Food and Drug , University of Parma , Parma , Italy.
Anna Karawajczykg Selvita S.A., Park Life Science , Kraków , Poland.
Aigars Jirgensonsc Latvian Institute of Organic Synthesis , Riga , Latvia.
Barbara Campaninib Laboratory of Biochemistry and Molecular Biology, Department of Food and Drug , University of Parma , Parma , Italy.
Gabriele Costantinoa P4T group, Department of Food and Drug, University of Parma, Parma, Italy.
University of Parma · ITLatvijas Organiskās Sintēzes Institūts · LVInstitute of Biostructure and Bioimaging · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The lack of efficacy of current antibacterials to treat multidrug resistant bacteria poses a life-threatening alarm. In order to develop enhancers of the antibacterial activity, we carried out a medicinal chemistry campaign aiming to develop inhibitors of enzymes that synthesise cysteine and belong to the reductive sulphur assimilation pathway, absent in mammals. Previous studies have provided a novel series of inhibitors for O-acetylsulfhydrylase - a key enzyme involved in cysteine biosynthesis. Despite displaying nanomolar affinity, the most active representative of the series was not able to interfere with bacterial growth, likely due to poor permeability. Therefore, we rationally modified the structure of the hit compound with the aim of promoting their passage through the outer cell membrane porins. The new series was evaluated on the recombinant enzyme from Salmonella enterica serovar Typhimurium, with several compounds able to keep nanomolar binding affinity despite the extent of chemical manipulation.

Indexed as

Anti-Bacterial AgentsCarboxylic AcidsCyclopropanesCysteine SynthaseDose-Response Relationship, DrugEnzyme InhibitorsEscherichia coliIsoenzymesMicrobial Sensitivity TestsMolecular StructureSalmonella typhimuriumStructure-Activity Relationship2-phenylcyclopropanecarboxylic acidAnti-Bacterial AgentsCarboxylic AcidsCyclopropanesCysteine SynthaseEnzyme InhibitorsIsoenzymesAntibacterialscysteineGram-negativesO-acetylserine sulfhydrylasepermeability

Identifiers

PMID30362368
PMCPMC6217552
OpenAlexW2898472834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.